Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 1
A Pilot Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation
The purpose of this study is to find a safe and tolerable way to improve engraftment after transplant. Research studies have shown that adding nicotinamide rib…
Allogeneic Hematopoietic Cell Transplantation
Case Comprehensive Cancer CenterNCT04332341
Observational
A Single Center Pilot Study of Intraoral Photobiomodulation Therapy for the Prevention of Oral Mucositis in Patients Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation
This is a single center pilot study evaluating intraoral photobiomodulation for the prevention of oral mucositis in patients undergoing myeloablative allogenei…
Myeloablative Allogeneic Hematopoietic Cell TransplantationIntraoral Photobiomodulation TherapyOral Mucositis+1 more
Dana-Farber Cancer InstituteNCT05335434
Phase 1
Phase 1 Trial for Patients With Advanced Hematologic Malignancies Undergoing Reduced Intensity Allogeneic HCT With a T-cell Depleted Graft With Infusion of Conventional T-cells and Regulatory T-cells
Reduced intensity conditioning (RIC) has emerged and been increasingly adopted as a modality to allow preparative conditioning pre transplant to be tolerated b…
Allogeneic Hematopoietic Cell Transplantation (HCT)Advanced Hematologic MalignanciesAcute Leukemia+3 more
Stanford UniversityNCT05088356
Phase 2
Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Diseases
Alemtuzumab is an antibody that reduces the strength of the immune system that is given in preparation for allogeneic hematopoietic cell transplant (HCT). In t…
Allogeneic Hematopoietic Cell Transplantation
Children's Hospital Medical Center, CincinnatiNCT05501756